Nasdaq agrx.

Apr 10, 2023 · The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current trading symbol "AGRX." NASDAQ:AGRX opened at $2.06 on Friday. The stock has a market capitalization of $5.17 million, a P/E ratio of -0.15 and a beta of 1.81. The company has a 50 day moving average price of $1.96 and a 200 day moving average price of $2.79. Agile Therapeutics has a fifty-two week low of $1.65 and a fifty-two week high of $16.00.He led investments in and served as chairman or director of Agile Therapeutics (NASDAQ: AGRX), Cernostics, Inc., Renal Solutions (acquired by Fresenius; NYSE: ...Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript. Mar 30, 2022. Apr 28, 2023 · PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla ...

PRINCETON, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that Al Altomari, Chairman and Chief ...PRINCETON, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common ...

Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's …

According to the issued ratings of 2 analysts in the last year, the consensus rating for Agile Therapeutics stock is Buy based on the current 2 buy ratings for AGRX. The average twelve-month price prediction for Agile Therapeutics is $8.50 with a high price target of $12.00 and a low price target of $5.00. Learn more on AGRX's analyst rating ...PRINCETON, N.J., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company, today announced positive top-line results from its ...PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ...PRINCETON, N.J., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a forward-thinking women’s healthcare company, today announced that it intends to offer and sell shares ...

Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ...

PRINCETON, N.J., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today provided an update on Twirla for 2022 and its commercial plan for ...

The new research reports from Fundamental Markets, available for free download at the links above, examine Halozyme Therapeutics, Inc. (NASDAQ:HALO), Capricor Therapeutics, Inc. (NASDAQ:CAPR ...PRINCETON, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2018 ...May 19, 2023 · Find the latest SEC Filings data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. Agile Therapeutics, Inc. Common Stock (AGRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. AGRX Option Chain. ... Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month ...

Nov 30, 2023 · The latest price target for Agile Therapeutics ( NASDAQ: AGRX) was reported by Maxim Group on Friday, September 22, 2023. The analyst firm set a price target for 5.00 expecting AGRX to rise to ... Agile Therapeutics Inc. (NASDAQ: AGRX) Agile Therapeutics Inc. (NASDAQ: AGRX) is a women's healthcare company dedicated to fulfilling the unmet health needs of today's women. Their product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a …May 19, 2023 · Find the latest SEC Filings data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. Nov 10, 2023 · Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript. Published on November 10, 2023 at 10:20 am by Insider Monkey Transcripts in News, Transcripts. Amy Welsh: Yes. Dec 1, 2023 · Agile Therapeutics (NASDAQ:AGRX) Now Covered by Analysts at StockNews.com americanbankingnews.com - November 26 at 2:52 AM: Agile Therapeutics (NASDAQ:AGRX) Stock Crosses Below 200 Day Moving Average of $2.67 americanbankingnews.com - November 25 at 3:54 AM: Agile Therapeutics reports Q3 results msn.com - November 23 at 8:51 AM May 25, 2023 · PRINCETON, N.J., May 25, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its ...

PRINCETON, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2018 ...

PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new ...PRINCETON, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon ...PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla ...Feb 27, 2023 · The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.” PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ...Sep 28, 2023 · Nasdaq Futures. 15,953.25 ... (NASDAQ:AGRX) to a "buy" rating. Agile Therapeutics is a women's healthcare company that is "dedicated to fulfilling the unmet needs of today's women." Its product ... Company now focused on completing plan to resubmit NDA in first half of 2019. PRINCETON, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare ...

EQS-News: Agile Therapeutics, Inc. NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 21.10.2022 / 17:00 CET/CEST The issuer is solely responsible for the...

And that’s a very complicated subject. Alfred Altomari Earnings Call Transcript Matt Riley NASDAQ:AGRX Q3 2023 Show more... Operator: Good morning, and welcome to the Agile Therapeutics Third ...

According to the issued ratings of 2 analysts in the last year, the consensus rating for Agile Therapeutics stock is Buy based on the current 2 buy ratings for AGRX. The average twelve-month price prediction for Agile Therapeutics is $8.50 with a high price target of $12.00 and a low price target of $5.00. Learn more on AGRX's analyst rating ...PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180 …PRINCETON, N.J., June 23, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today praised the Executive Order issued by President Biden that ...18 Feb 2020 ... Agile Therapeutics Inc (NASDAQ:AGRX) announced Tuesday that the US Food and Drug Administration (FDA) has approved Twirla, a new non-daily ...Apr 26, 2022 · The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX." Summary. Real-Time. After-Hours. Pre-Market Live. Charts. AGRX AGRX AFTER HOURS QUOTE AGRX LATEST AFTER HOURS TRADES.PRINCETON, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months and year ended ...Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180 …Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced an agreement with vitaCare Prescription Services, a wholly owned subsidiary of GoodRx, to expand patient ...

EQS-News: Agile Therapeutics, Inc. NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 21.10.2022 / 17:00 CET/CEST The issuer is solely responsible for the...AGRX Option Chain. ... Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month ... Agile Therapeutics Inc (NASDAQ:AGRX) is the most popular stock in this table. On the other hand Clearfield, Inc. (NASDAQ: CLFD ) is the least popular one with only 3 bullish hedge fund positions.Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.Instagram:https://instagram. how to set up a day trading accountthe tattooed chefis gm a good stock to buycronos group inc (NASDAQ: AGRX) Agile Therapeutics currently has 2,511,657 outstanding shares. With Agile Therapeutics stock trading at $2.13 per share, the total value of Agile ...PRINCETON, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2022 ... nasdaq cdmotradingview plans PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today publicly released the findings of its first year of post-marketing ...Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58. pharmaceutical stocks to buy If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...